The global Hepatitis C Drug market will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drug: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/hepatitis-c-drug-market-101562
Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stages of hepatitis C can also lead to liver damage, thereby creating severe health risks. The severity of hepatitis C has created a huge emphasis on the research and development of drugs associated with the treatment of this disease. Several new drugs have been launched in recent times, due to the high prevalence of hepatitis C across the world. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage.
Top players in the global Type 1 Hepatitis C Drug Market include:
Request a Sample Copy of the Global Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hepatitis-c-drug-market-101562
Increasing Drug Approvals Will Favor Market Growth
The escalating demand for Hepatitis C Drug has yielded several regulatory approvals for associated drugs. Fortune Business Insights has predicted that increasing regulatory approvals for related drugs and recombinant products will constitute an increase in the global Hepatitis C Drug market value in the coming years. The Hepatitis C Drug industry has witnessed numerous drug approvals in recent years driven by the increasing fatality rate of the disease. In April 2019, the United States Food and Drug Administration passed approval for Mavyret for the treatment of hepatitis C in pediatric patients.
The Mavyret was the first treatment for all genotypes of hepatitis C. The 2017 approval for the same drug was aimed at the treatment of hepatitis C, but in patients without cirrhosis or mild cirrhosis of the liver. Fortune Business Insights has predicted that AbbVie’s successful drug approval will help the company generate a substantial amount of hepatitis C market value. The report includes some major regulatory approvals of recent times and gauges the impact of these drug approvals on the global Hepatitis C Drug market.
Segmentation of Hepatitis C Drug Market:
Hepatitis C Drug Market Segments by Product Type
Hepatitis C Drug Market Segments by Disease Type
By Distribution Channel
By Geography
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hepatitis-c-drug-market-101562
Table of Content from Hepatitis C Drug Market:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Hepatitis C by Key Countries
4.2. Pipeline Analysis
4.3. Regulatory Scenario by Key Regions
4.4. Pricing Analysis
4.5. Overview of Genotypes of Hepatitis C by Key Regions
4.6. New Product Launches
4.7. Key Industry Developments
5. Global Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Product Type
5.2.1. NS5A Inhibitor (Protease Inhibitors)
5.2.2. Fixed-dose Combination
5.2.3. Others
5.3. Market Analysis, Insights and Forecast By Disease Type
5.3.1. Acute Hepatitis C
5.3.2. Chronic Hepatitis C
5.4. Market Analysis, Insights and Forecast By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies
5.4.3. Online Pharmacies
5.4.4. Others
5.5. Market Analysis, Insights and Forecast By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
More Trending Topics From Fortune Business Insights
X-Ray Flat Panel Detectors Market Size, Regional Analysis and 2025 Forecast
Thrombin Market Size Share Growth and Industry Analysis 2026
Retinal Disease Therapeutics Market Size, Regional Analysis and 2025 Forecast
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Website: Fortune Business Insights
Follow us on:
LinkedIn | Twitter | Blogs
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Hepatitis C Drug Market to Reach US$ 7,351.7 Mn by 2026| Fortune Business Insights